Literature DB >> 17404416

Late stent thrombosis associated with coronary aneurysm formation after sirolimus-eluting stent implantation.

Shahid Aziz1, John L Morris, Raphael A Perry.   

Abstract

Stent thrombosis is a rare but potentially fatal complication of coronary stent implantation. Its occurrence late after drug-eluting stent (DES) deployment has led to concerns regarding their long-term safety. We report a case of late stent thrombosis 26 months after sirolimus-eluting stent (SES) (Cypher, Cordis Corp., Miami, Florida) implantation. This was associated with marked positive vessel remodeling and coronary aneurysm formation involving the stented segment of the coronary artery. The patient was on dual antiplatelet therapy at the time.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404416

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  9 in total

1.  Drug-eluting stents.

Authors:  Xiaodong Ma; Tim Wu; Michael P Robich; Xingwei Wang; Hao Wu; Bryan Buchholz; Stephen McCarthy
Journal:  Int J Clin Exp Med       Date:  2010-07-15

Review 2.  Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review.

Authors:  Sharad Bajaj; Rupen Parikh; Aiman Hamdan; Mahesh Bikkina
Journal:  Tex Heart Inst J       Date:  2010

3.  A case of coronary artery aneurysm after sirolimus-eluting stent implantation presenting with unstable angina due to progression of stent thrombosis: Concerns over sirolimus-eluting stents remain.

Authors:  Shogo Matsui; Shuntaro Ikeda; Jun Aono; Haruhiko Higashi; Kiyotaka Ohshima; Mareomi Hamada
Journal:  J Cardiol Cases       Date:  2016-09-03

4.  Stent thrombosis with an aneurysm 7 years after a drug eluting stent implantation.

Authors:  Pritam Patil; Arvind Sethi; Upendra Kaul
Journal:  Indian Heart J       Date:  2014-03-27

5.  A case of a zotarolimus-eluting stent fracture in the left anterior descending artery in a patient undergoing hemodialysis.

Authors:  In Hye Cha; Seong Hwan Kim; Sang Yup Lim; Jeong Chun Ahn; Woo Hyuk Song
Journal:  Chonnam Med J       Date:  2011-04-26

6.  Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention.

Authors:  Guo-Hua Zheng; Jian-Ping Liu; Nissi S Wang; Hai-Ying Chen; Jian-Feng Chu
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-16       Impact factor: 2.629

Review 7.  Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies.

Authors:  Xiaochen Yang; Xingjiang Xiong; Heran Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-24       Impact factor: 2.629

8.  A rare complication of percutaneous coronary intervention: Coronary pseudoaneurysm formation.

Authors:  Oğuzhan Çelik; Lütfü Bekar; Mucahit Yetim; Tolga Doğan; Çağlar Alp; Macit Kalçık; Yusuf Karavelioğlu
Journal:  Interv Med Appl Sci       Date:  2017-12

9.  The effects of xuefu zhuyu and shengmai on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris after percutaneous coronary intervention: a randomised controlled clinical trial.

Authors:  Jie Wang; Xiaochen Yang; Fuyong Chu; Jianxin Chen; Qingyong He; Kuiwu Yao; Fei Teng; Yonghong Gao; Yanhui Xing; Aiming Wu; Yanwei Xing
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-08       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.